People Juan Pablo Rigalli

Contact

Juan Pablo Rigalli PhD

+31 (0)24 361 42 02
contact

Juan Pablo Rigalli postdoc

Juan Pablo Rigalli (b. 1985) obtained his Master's degree in Biotechnology (2009) and his PhD in Biological Sciences (2013) at Rosario University in Argentina.

read more

Juan Pablo Rigalli postdoc

Juan Pablo Rigalli (b. 1985) obtained his Master's degree in Biotechnology (2009) and his PhD in Biological Sciences (2013) at Rosario University in Argentina. During this early phase of his career he worked in the field of molecular pharmacology and studied the potential of therapeutic agents like the trypanocidal benznidazole to act as a perpretator of drug-drug interactions, specially by regulation of ATP binding cassette (ABC) drug transporters. He has been always interested in the molecular mechanisms underlying pharmacological effects and interactions. In 2015 he moved to Heidelberg (Germany) where he was awarded a research grant from the German Research Foundation (DFG) to evaluate the interaction between human papillomaviruses, ABC transporters and multidrug resistance in head and neck squamous cell carcinoma. In January 2018 he joined the group of ion transport.

His projects are:
  • establishing a model of human kidney organoids to study patho(physiological) processes related to the electrolyte balance
  • evaluating the role of ATP as a signalling molecule in the modulation of renal electrolyte handling

Personal prizes & awards national & international

  • 2018: Radboud Excellence Initiative (Fellowship)
  • 2015: Research grant. German Research Foundation (DFG)
read more

Personal prizes & awards national & international

  • 2018: Radboud Excellence Initiative (Fellowship)
  • 2015: Research grant. German Research Foundation (DFG)
  • 2015: Alexander von Humboldt Foundation: Postdoctoral Fellowship

Field of study

Physiology

Radboud Institute for Molecular Life Sciences

Our main aim is to achieve a greater understanding of the molecular mechanisms of disease. By integrating fundamental and clinical research, we obtain multifaceted knowledge of (patho)physiological processes. read more